Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Trio Solutions, LLC, a prominent player in the pharmaceutical consulting industry, is headquartered in the United States. Founded in 2010, the company has established itself as a trusted partner for pharmaceutical and biotech firms, offering specialised services in regulatory affairs, clinical development, and market access strategies.
Fulcrum Pharma plc, based in the UK, complements Trio Solutions with its focus on drug development and commercialisation, particularly in the rare disease sector. Established in 2015, Fulcrum Pharma has made significant strides in advancing innovative therapies, leveraging its expertise to navigate complex regulatory landscapes.
ADDPLAN GmbH, located in Germany, enhances this collaboration by providing cutting-edge software solutions for clinical trial planning and management. Founded in 2012, ADDPLAN is recognised for its unique approach to optimising trial designs, ensuring efficiency and compliance. Together, these companies form a robust alliance, driving advancements in the pharmaceutical landscape and delivering exceptional value to their clients.
No reported emissions data is available for Trio Solutions, LLC and Fulcrum Pharma plc and ADDPLAN GmbH yet.
Trio Solutions, LLC, Fulcrum Pharma plc, and ADDPLAN GmbH currently do not have available carbon emissions data for the most recent year, as indicated by the absence of specific emissions figures. Consequently, there are no reported totals for Scope 1, Scope 2, or Scope 3 emissions, nor any significant reduction targets or achievements documented.
The organisations are part of a merged entity, inheriting their climate commitments and initiatives from their corporate family. However, specific details regarding their climate strategies, such as Science-Based Targets Initiative (SBTi) commitments or other reduction initiatives, are not provided.
As a merged entity, they may be aligned with broader industry standards and practices regarding carbon emissions and climate action, but without specific data or commitments outlined, it is challenging to provide a detailed overview of their environmental impact or future goals.
No climate goals have been disclosed for Trio Solutions, LLC and Fulcrum Pharma plc and ADDPLAN GmbH yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more